PROCEPT BioRobotics Corporation (PRCT)
NASDAQ: PRCT · Real-Time Price · USD
28.40
-0.68 (-2.34%)
At close: Nov 18, 2025, 4:00 PM EST
28.96
+0.56 (1.97%)
After-hours: Nov 18, 2025, 6:39 PM EST
PROCEPT BioRobotics Revenue
PROCEPT BioRobotics had revenue of $83.33M in the quarter ending September 30, 2025, with 42.76% growth. This brings the company's revenue in the last twelve months to $299.91M, up 50.07% year-over-year. In the year 2024, PROCEPT BioRobotics had annual revenue of $224.50M with 64.84% growth.
Revenue (ttm)
$299.91M
Revenue Growth
+50.07%
P/S Ratio
5.21
Revenue / Employee
$396,702
Employees
756
Market Cap
1.59B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 224.50M | 88.31M | 64.84% |
| Dec 31, 2023 | 136.19M | 61.18M | 81.55% |
| Dec 31, 2022 | 75.01M | 40.54M | 117.60% |
| Dec 31, 2021 | 34.47M | 26.76M | 346.72% |
| Dec 31, 2020 | 7.72M | 1.55M | 25.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
PRCT News
- 14 days ago - PROCEPT BioRobotics Corporation (PRCT) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 14 days ago - PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance - GlobeNewsWire
- 4 weeks ago - PROCEPT BioRobotics® to Report Third Quarter 2025 Financial Results on November 4, 2025 - GlobeNewsWire
- 6 weeks ago - Procept BioRobotics: A Strong Challenger Positioned To Be A Future Leader - Seeking Alpha
- 3 months ago - Procept BioRobotics: Increasing Average Selling Price, Initiate At Buy - Seeking Alpha
- 3 months ago - PROCEPT BioRobotics Corporation (PRCT) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance - GlobeNewsWire
- 4 months ago - PROCEPT BioRobotics® President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO - GlobeNewsWire